Bay City Capital LLC
- SEC CIK
- 0001288452
No open-market purchases or sales filed in the past year.
Current role at each company
- MDGL Madrigal Pharmaceuticals, Inc.10% Owneras of Dec 7, 2021
- XLO Xilio Therapeutics, Inc.10% Owneras of Oct 26, 2021
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Bay City Capital LLC as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
XLO Xilio Therapeutics, Inc.
10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 26, 2021 (view filing) | Oct 26 | Same day | Bay City Capital LLC10% Owner | PPurchase | +312.5K | $16.00 | +$5.00M | +38.3%1.13M after |